Catastrophic retroperitoneal hemorrhage in COVID-19 patients under anticoagulant prophylaxis
- PMID: 33520659
- PMCID: PMC7829136
- DOI: 10.1016/j.eucr.2021.101568
Catastrophic retroperitoneal hemorrhage in COVID-19 patients under anticoagulant prophylaxis
Abstract
COVID-19 patients are at high risk for both capillary micro thrombi and large vessel thrombosis. Anticoagulant administration in COVID-19 patients, especially in ICU setting, is recommended by some researchers. However, clinical guidelines don't yet recommend anticoagulation therapies in therapeutic doses in these patients. In this article, we try to introduce a less known complication of heparin application in COVID-19 patients. Retroperitoneal hemorrhage when involves the psoas muscle might be deadly because of the large volume of bleeding before causing any significant alarm. It is very important to be careful in diagnosing and managing this complication.
© 2021 Published by Elsevier Inc.
Figures
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
